UNSPSC 51152003: Rocuronium

This classification denotes a nicotinic antagonist with the molecular formula C32H53N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WRE554RFEZ. European Medicines Agency schedules rocuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04260MIG. ROCURONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ROCURONIUM remains the US FDA Preferred Term for this commodity.

Rocuronium bears US NLM identifiers UMLS ID C0209337 and NCI Concept Code C80999. SMILES: O(C1C2(C(C3C(C4(C(CC3)CC(O)C(N3CCOCC3)C4)C)CC2)CC1[N]1(CCCC1)CC=C)C)C(=O)C.

UNSPSC 51152003 Rocuronium is a Commodity code that does not reflect the work actually being solicited under this code number in recent state and local procurement. The single recorded opportunity from Seminole County, Florida—an IFB posted June 30, 2026, due July 26, 2026—sought Naloxone and safe drug deactivation systems, not rocuronium, a neuromuscular blocking agent used in anesthesia and critical care. The mismatch between the code's nominal scope and the stated procurement suggests either a data error or misclassification in the county's tagging system. State and local procurement activity under this specific code shows insufficient recent data to characterize the actual scope of work, issuing-body mix, or purchasing patterns.

No representative opportunities demonstrating rocuronium procurement were identified in the source. Potential buyers evaluating this code should verify the UNSPSC classification with the issuing jurisdiction before pursuing opportunities tagged with this number, as the recent activity does not validate the code's intended commodity scope.